DORIBAX

LOE Approaching

doripenem

NDAINTRAVENOUSINJECTABLE
Approved
Oct 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
19

Clinical Trials (5)

NCT01599806Phase 3Completed

Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

Started Oct 2012
641 enrolled
Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
NCT01595438Phase 3Completed

Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

Started Oct 2012
598 enrolled
Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
NCT01366651Phase 1Terminated

A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of Age

Started Mar 2012
1 enrolled
Meningitis
NCT01110382Phase 3Terminated

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

Started Dec 2010
41 enrolled
Abscess, Intra-AbdominalAbdominal AbscessAbdomen, Acute+7 more
NCT01110408Phase 3Terminated

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

Started Dec 2010
41 enrolled
Complicated Urinary Tract Infections or Pyelonephritis